Should rosuvastatin be withdrawn from the market?

S.R. Florentinus; E.R. Heerdink; O.H. Klungel; A. de Boer

Should rosuvastatin be withdrawn from the market?

S.R. Florentinus
, E.R. Heerdink
, O.H. Klungel
, A. de Boer

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	1577-1580
Number of pages	4
Journal	The Lancet
Volume	364
Publication status	Published - 2004

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

Boer 04 FlorentinusShouldRosuvastatinBeWithdrawn
Open Access (free)

Cite this

@article{1303fd10398c42d8a3d675bcb97e0d5d,

title = "Should rosuvastatin be withdrawn from the market?",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "S.R. Florentinus and E.R. Heerdink and O.H. Klungel and \{de Boer\}, A.",

year = "2004",

language = "Undefined/Unknown",

volume = "364",

pages = "1577--1580",

journal = "The Lancet",